NEOGENOMICS INC - 8-K Filing
NeoGenomics issued $316.25 million in aggregate principal amount of 0.75% Convertible Senior Notes due 2032, including an additional $41.25 million from exercised options by initial purchasers on June 17, 2026. The company also repurchased approximately $276 million in existing notes for about $263.19 million and entered into capped call transactions to mitigate dilution effects of the new convertible notes. (Items: 1.01 of this Current Report on Form 8-K is incorporated herein by reference)
Tickers: $NEO